Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

They identified patients with lymphoid leukemia that switched to myeloid leukemia ... a PhD candidate in the Termini Lab at Fred Hutch Cancer Center. She studies how acute myeloid leukemia cells ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

For a school going child with thalassemia juggling the stress of monthly checkpoints with the hassle of monthly transfusions, the possibility of a permanent cure for the chronic condition is a ray of ...

Brookline Capital Markets initiated coverage on Marker Therapeutics (NASDAQ:MRKR), a company focused on developing T cell-based immunotherapies for cancer, with a Buy rating and a 12-to-18-month price ...

New research suggests that firstborn twins may have a greater risk of developing leukemia than second-born twins.

Additional support was provided by the Leukemia and Lymphoma Society Translational ... Oh ST. RSK1 dependency in FLT3-ITD acute myeloid leukemia. Blood Cancer Journal. Nov. 26, 2024.